A Phase I Study Of Weekly Taxotere (Docetaxel) And Gleevec (STI571, Imatinib Mesylate, CGP 57148B) In Locally Advanced Or Metastatic Breast Cancer.
Phase of Trial: Phase I
Latest Information Update: 23 May 2018
At a glance
- Drugs Docetaxel (Primary) ; Imatinib (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 21 Apr 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 21 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.